Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel ReportJoshua A. Boyce, Julie M. Schwaninger, Carol Byrd‐Bredbenner et al.|Journal of Allergy and Clinical Immunology|2010Cited by 2.3k
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut AllergyDavid M. Fleischer, Wayne G. Shreffler, Matthew Greenhawt et al.|JAMA|2019Cited by 271
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ. Andrew Bird, A. Wesley Burks, Jonathan M. Spergel et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 200
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic IndividualsSandra Andorf, Kari C. Nadeau, Natasha Purington et al.|EClinicalMedicine|2019Cited by 132
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M. Fleischer, Hugh A. Sampson, Wayne G. Shreffler et al.|Journal of Allergy and Clinical Immunology|2020Cited by 101